Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Tuberculosis Research and Epidemiology, and Immune Response and Inflammation.
An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4+ T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosis